NEW YORK (GenomeWeb) – Oxford Gene Technology (OGT) today announced a licensing deal for its SNP array probe technology with Baylor Miraca Genetics Laboratories (BGML).
Financial and other terms of the agreement were not disclosed.
"Through the application of OGT's technology, we are now able to provide reliable array-based analysis of both copy number variation and loss of heterozygosity for challenging samples," BMGL VP of Operations Sean Kim said in a statement. "We are now also looking to other areas of genetic analysis, expanding the use of this technology toward our complete portfolio."
BGML is a joint venture between Baylor College of Medicine and Japan's Miraca Holdings, providing genomic services in the US and internationally. The lab said in a statement that OGT's SNP probes, which are designed to target each SNP allele, provide an alternative to restriction enzyme-based approaches, which are unable to accurately analyze small amounts of DNA.
The licensing deal follows OGT's decision to focus on genomic products, announced in September, when the firm began directing its genomic services customers to Source BioScience. The firm also sold its protein array platform to Sengenics that month for an undisclosed amount.